News

The partnership will identify important characteristics of diseased fibrotic tissue on which Epistem will apply its proprietary RNA-Amp technology to facilitate building an in depth understanding of the

The new AMPAKINE patents cover a series of compounds including CX2007 and CX2076, which exhibit a long duration of action and pharmacokinetic properties through August 2028. The company

The FDA had visited the Aveva manufacturing facility where ONSOLIS is produced and reported the formation of microscopic crystals and fading of the color during the 24-month shelf

Both the companies have agreed to move forward independently. As of 12 March 2012, all rights licensed to Pfizer will revert to Biocon, and all insulin distributed under

Pulmaquin is a once-a-day novel inhaled formulation consisting of a proprietary mixture of unencapsulated ciprofloxacin and ciprofloxacin encapsulated in liposomes. The formulation allows for both immediate and sustained

As per the Indian Patents Act, Natco Pharma will be able to make and sell low-cost drug in the country, through a pact with the patent holder, at

The company’s submission provides information to the FDA on Prurisol supporting a pre-IND meeting. With the meeting, Cellceutix intends for guidance to attain approval for a section 505(b)(2)

The project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells in EMD Millipore’s Mobius CellReady

Immunovaccine said the new vaccine would prevent cocaine molecules from reaching the brain by stimulating the body’s own immune system. As part of the project, Cornell’s novel cocaine